BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23494926)

  • 1. Diffusion kurtosis imaging to detect amyloidosis in an APP/PS1 mouse model for Alzheimer's disease.
    Vanhoutte G; Pereson S; Delgado Y Palacios R; Guns PJ; Asselbergh B; Veraart J; Sijbers J; Verhoye M; Van Broeckhoven C; Van der Linden A
    Magn Reson Med; 2013 Apr; 69(4):1115-21. PubMed ID: 23494926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-β-induced pathology.
    Praet J; Manyakov NV; Muchene L; Mai Z; Terzopoulos V; de Backer S; Torremans A; Guns PJ; Van De Casteele T; Bottelbergs A; Van Broeck B; Sijbers J; Smeets D; Shkedy Z; Bijnens L; Pemberton DJ; Schmidt ME; Van der Linden A; Verhoye M
    Alzheimers Res Ther; 2018 Jan; 10(1):1. PubMed ID: 29370870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between microstructural alterations and severity of cognitive deficiency in Alzheimer's disease and mild cognitive impairment: a diffusional kurtosis imaging study.
    Gong NJ; Wong CS; Chan CC; Leung LM; Chu YC
    Magn Reson Imaging; 2013 Jun; 31(5):688-94. PubMed ID: 23347602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does diffusion kurtosis imaging lead to better neural tissue characterization? A rodent brain maturation study.
    Cheung MM; Hui ES; Chan KC; Helpern JA; Qi L; Wu EX
    Neuroimage; 2009 Apr; 45(2):386-92. PubMed ID: 19150655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer's disease.
    Zheng H; Zhou Q; Du Y; Li C; Xu P; Lin L; Xiao J; Gao H
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):263-273. PubMed ID: 29107091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion kurtosis imaging of the human kidney: a feasibility study.
    Pentang G; Lanzman RS; Heusch P; Müller-Lutz A; Blondin D; Antoch G; Wittsack HJ
    Magn Reson Imaging; 2014 Jun; 32(5):413-20. PubMed ID: 24582288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast diffusion kurtosis imaging of fibrotic mouse kidneys.
    Kjølby BF; Khan AR; Chuhutin A; Pedersen L; Jensen JB; Jakobsen S; Zeidler D; Sangill R; Nyengaard JR; Jespersen SN; Hansen B
    NMR Biomed; 2016 Dec; 29(12):1709-1719. PubMed ID: 27731906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of diffusional kurtosis tensor imaging in prostate MRI for the assessment of prostate cancer: preliminary results.
    Quentin M; Pentang G; Schimmöller L; Kott O; Müller-Lutz A; Blondin D; Arsov C; Hiester A; Rabenalt R; Wittsack HJ
    Magn Reson Imaging; 2014 Sep; 32(7):880-5. PubMed ID: 24848289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Amyloidosis and BDNF Deficiency Have Opposite Effects on Brain Volumes in AβPP/PS1 Mice Both in vivo and ex vivo.
    Kärkkäinen E; Lahtinen HM; Närväinen J; Gröhn O; Tanila H
    J Alzheimers Dis; 2015; 46(4):929-46. PubMed ID: 26402627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurophysiological effects of human-derived pathological tau conformers in the APPKM670/671NL.PS1/L166P amyloid mouse model of Alzheimer's disease.
    Tok S; Maurin H; Delay C; Crauwels D; Manyakov NV; Van Der Elst W; Moechars D; Drinkenburg WHIM
    Sci Rep; 2022 May; 12(1):7784. PubMed ID: 35546164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion Kurtosis Imaging Detects Microstructural Alterations in Brain of α-Synuclein Overexpressing Transgenic Mouse Model of Parkinson's Disease: A Pilot Study.
    Khairnar A; Latta P; Drazanova E; Ruda-Kucerova J; Szabó N; Arab A; Hutter-Paier B; Havas D; Windisch M; Sulcova A; Starcuk Z; Rektorova I
    Neurotox Res; 2015 Nov; 28(4):281-9. PubMed ID: 26153486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards better MR characterization of neural tissues using directional diffusion kurtosis analysis.
    Hui ES; Cheung MM; Qi L; Wu EX
    Neuroimage; 2008 Aug; 42(1):122-34. PubMed ID: 18524628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
    El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M
    Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits.
    Jardanhazi-Kurutz D; Kummer MP; Terwel D; Vogel K; Dyrks T; Thiele A; Heneka MT
    Neurochem Int; 2010 Nov; 57(4):375-82. PubMed ID: 20144675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
    Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY
    Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo quantitative whole-brain diffusion tensor imaging analysis of APP/PS1 transgenic mice using voxel-based and atlas-based methods.
    Qin YY; Li MW; Zhang S; Zhang Y; Zhao LY; Lei H; Oishi K; Zhu WZ
    Neuroradiology; 2013 Aug; 55(8):1027-1038. PubMed ID: 23644540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.